Delving into the Latest Updates on Rose Pharma with Synapse

概览

疾病领域	数量

内分泌与代谢疾病	1

排名前五的药物类型	数量

重组多肽	1

排名前五的靶点	数量

GLP-1R(胰高血糖素样肽-1受体)	1

关联

1

项与 Rose Pharma 相关的药物

ROSE-010

靶点

GLP-1R

作用机制

GLP-1R激动剂

在研机构

原研机构

在研适应症

非在研适应症

最高研发阶段临床2期

首次获批国家/地区-

首次获批日期-

1

项与 Rose Pharma 相关的临床试验

NCT06621017

/ Not yet recruiting临床2期

A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Daily Administrations of the GLP-1 Analogue ROSE-010 on Appetite and Food Intake in Overweight and Obese Subjects

The primary objective of this study is to assess the efficacy of ROSE-010 on food intake in female subjects with overweight and obesity.
The secondary objectives of this study are the following:
* To assess the efficacy of ROSE-010 on hunger;
* To assess the efficacy of ROSE-010 on satiety;
* To assess the efficacy of ROSE-010 on prospective consumption;
* To assess the efficacy of ROSE-010 on desire to eat;
* To assess the efficacy of ROSE-010 on palatability;
* To characterize the pharmacokinetics (PK) of ROSE-010 following subcutaneous (SC) administration on Day 1 and Day 7; and
* To evaluate safety and tolerability of SC administrations of ROSE-010 to overweight and obese subjects.

开始日期2024-10-01

申办/合作机构

Rose Pharma

100 项与 Rose Pharma 相关的临床结果

登录后查看更多信息

0 项与 Rose Pharma 相关的专利（医药）

登录后查看更多信息

100 项与 Rose Pharma 相关的药物交易

登录后查看更多信息

100 项与 Rose Pharma 相关的转化医学

登录后查看更多信息